个股
共 6,296 份研报 · 国内 4,037 · 国外 1,841
奥普特(688686.SH):26年第三季度净利润超预期,毛利率虽不及预期但看好27年AI检测
OPT Machine Vision (688686.SS): 3Q26 Earnings Strong Beat Despite GPM Miss, Upbeat on AI Inspection for 2027
花旗·2026-10-27·14 页·科创板
RELX PLC(REL.L):维持展望;缺乏近期催化剂
RELX PLC (REL.L): Outlook maintained; lack of near-term catalysts
花旗·2026-10-27·13 页·其它
Orange(ORAN.PA):第三季度业绩强劲,EBITDAaL指引上调
花旗·2026-10-27·11 页·其它
DigitalOcean Holdings(DOCN.N)26财年三季报前瞻:在极具吸引力的风险回报比下亮点颇多
DigitalOcean Holdings, Inc. (DOCN.N) 3Q26E Preview: Plenty to Like Against Compelling Risk/Reward
花旗·2026-10-27·16 页·美股
捍卫股价:217暴跌违背逻辑的七大理由
ArriVent BioPharma Inc. (AVBP.O): Defending Stock. 7 Reasons Why The '217 Selloff Defies Logic.
花旗·2026-10-27·12 页·美股
argenx(ARGX.O)2026年三季报回顾与模型更新:12月聚焦Empasiprubart治疗MMN的数据读出;目标价调整至1,232美元/股
argenx (ARGX.O) 3Q26 Recap & Model Update: All Eyes on Empasiprubart MMN Readout in December; TP to $1,232/shr
花旗·2026-10-27·15 页·美股
智飞生物(300122.SZ):财报点评:26年第三季度业绩超预期且经营现金流改善;目标价上调至19元,维持买入
Zhifei (300122.SZ): Earnings review: 3Q26 results beat with OCF improving; TP up to Rmb19; Buy
北京高华证券·2026-10-27·7 页·创业板
高盛-英维克(002837.SZ)初评:26年第三季度销售额符合高盛预期,净利润逊于预期;合同负债与存货创新高预示未来收入加速确认;买入
Shenzhen Envicool Technology (002837.SZ) First Take: 3Q26 sales inline with GSe, NP miss; Record contract liabilities and inventories point to accelerating revenue bookings ahead; Buy
高盛·2026-10-27·10 页·A股
怡合达(301029.SZ):受益于电子与半导体业务敞口,26年第三季度业绩超预期
Yiheda Automation (301029.SZ): 3Q26 beat led by electronics and semiconductor exposure; Buy
北京高华证券·2026-10-27·9 页·创业板
双环传动(002472.SZ):2026年第三季度业绩符合预期,汽车零部件业务跑赢行业,市场更关注AI机器人齿轮业务
Shuanghuan Driveline (002472.SZ): 3Q26 in line; more focus on AI robotics gears with auto components outperforming industry
高盛·2026-10-27·8 页·A股
诺华(NOVN.S):2026年三季度初步点评:成本控制持续驱动盈利增长,指引上调暗示核心业务存在约2%的上行空间
Novartis (NOVN.S): 3Q26 First take: Cost control continues to drive earnings momentum, guidance upgrade suggests 2% upside risk to Core Operating Profit
高盛·2026-10-27·10 页·其它
晶合集成(688249.SS):2026年四季度指引符合季节性,三季度营业利润优于预期;维持中性
Nexchip (688249.SS): 4Q26 guidance meet seasonality, 3Q26 OP income better than expected; Neutral
高盛·2026-10-27·9 页·科创板
汇丰控股(0005.HK/HSBA.L):2026年三季度初评:营收偏弱但被较低减值抵消,整体符合预期;宣布最高10亿美元回购
HSBC (0005.HK/HSBA.L): 3Q26 First Take: Inline with softer revenues offset by lower impairments; up to $1bn buyback announced
高盛·2026-10-27·9 页·港股
国瓷材料(300285.SZ)财报点评:26年第三季度营收超预期但受利润率走弱及一次性因素拖累;AI材料出货量将于第四季度启动;中性
Sinocera Functional Material (300285.SZ) Earnings Review: 3Q26 revenue beat tempered by softer margins and one-offs; AI materials shipments set to begin in 4Q; Neutral
北京高华证券·2026-10-27·10 页·创业板
格力电器(000651.SZ):26年第三季度初评:营收符合预期但受制于毛利率压力利润不及预期
Gree Electric Appliances Inc. (000651.SZ): 3Q26 First Take: Revenue in-line but profits missed on elevated GPM pressure; Neutral
北京高华证券·2026-10-27·8 页·A股
福斯特(603806.SH):26年三季度业绩不及预期,管理层下调26年指引并引入27年目标;盈利前景仍具建设性,重申买入
HANGZHOU FIRST APPLIED MATERIAL (603806.SS): 3Q26 miss; Mgmt. lowered FY26 guidance and introduced FY27 target; reiterate Buy as constructive earnings outlook remains intact
北京高华证券·2026-10-27·7 页·A股
阿斯利康(AZN.L):ESMO会议要点:sone-ve三线数据令人信服,二线数据更微妙;AVANZAR延期
AstraZeneca (AZN.L): ESMO takeaways: sone-ve 3L data compelling, 2L more nuanced; AVANZAR delayed
高盛·2026-10-27·13 页·其它
提高OLX估值;根据腾讯股价走势更新估值
PROSUS/NASPERS: Increasing OLX valuation; Updating valuation for Tencent share price moves
北京高华证券·2026-10-27·14 页·其它
科伦博泰生物(6990.HK):科伦与默沙东合作的sac-TMT在子宫内膜癌领域斩获首个全球III期临床胜利
科伦博泰生物 (6990.HK): Kelun / Merck's sac-TMT scores the first global Ph3 win in endometrial cancer
伯恩斯坦·2026-10-27·14 页·港股
Food & Life(寿司郎,3563.JP)2026财年第四季度前瞻:业绩再超预期,但2027财年基数较高
Food & Life (Sushiro) FY4Q26 preview: Another beat yet a high bar for FY27
伯恩斯坦·2026-10-27·19 页·其它
显示 3341 - 3360 条,共 6,296 条